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N-bromoacetyl-3,3’,5-tri[3’-1z5I]iodo-L-thyronine was used to label intact heart mitochondria from eu-, hypo- and hy- 
perthyroid rats in order to identify proteins involved in T3-regulated mitochondrial processes. The results show strong 
labeling, competed for by T3 and other analogues, of two proteins with a molecular mass of 48 000 and 49 200 Da. 
No labeling is seen of the adenine nucleotide translocase, a likely target, neither at O’C, at room temperature, nor after 
preincubation with the substrates or sgecifrc inhibitors. No difference in labeling intensity or dist~bution is seen in mito- 
chondria from eu-, hypo- or hyperthyroid rats, and the abundance of the adenine nucleotide translocase is unchanged, 
but five other proteins show diffe~nti~ abundance. 
Bromo~tyl-3,~,5-t~[~-1*s~~~o-L-thyronine, N-; Adenine nucleotide translocase; Thyroid hormone; (Rat heart mitochondria) 
1. INTRODUCTION 
Various effects of thyroid hormone on 
mitochondrial processes have been reported. In 
vivo 3,3 ’ ,5-triiodo-L-thyronine (T3) administra- 
tion to rats induces a change in mitochondrial 
transcription and translation in heart, liver and 
kidney [l-4]. Also, change in the number and ac- 
tivity of respiratory components [S], increased 
oxygen consumption, a decrease in the ATP/ADP 
ratio inside the mitochondria and an increase in the 
cytosol are persisting effects [6]. Earlier reports 
suggested the adenine nucleotide translocase 
(ANT) as a target for direct T3 regulation of 
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mitochondrial activity [6-81. Since this protein has 
recently been well characterized from heart tissue 
by its activity [9], SDS-PAGE mobility [lo], pep- 
tide maps and Western blotting [ 111, and by cDNA 
cloning [ 121, it would be of interest to further 
characterize a possible T3 binding site in the ANT. 
Experimentally induced hyper- and 
hypothyroidism in rats has been shown not to 
change the gene expression of the ANT 1131; a 
possible T3 effect is therefore expected to be 
directly on the catalytic activity of the ANT. 
‘“I-labeled ~-bromoacetyl-T3 (BrAc[‘251]T3) 
was used for affinity labeling of intact mitochon- 
dria, since it has been used earlier to successfully 
label T3 receptors and T3 binding proteins in situ 
[14-161. The integrity of BrAc[1251]T3 was nalyz- 
ed by high-performance liquid chromatography 
(HPLC) during the labeling of whole mitochon- 
dria. Labeling intensities and the abundance of the 
ANT and other proteins were compared in hypo-, 
eu-, and hyperthyroid rat heart mitochondria. 
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2. MATERIALS AND METHODS 
2.1. Treatment of rats 
7-week-old male Lewis rats (approximately 200 g body wt) 
were used in all experiments. Hyper- and hypothyroidism was 
obtained by daily S.C. injections of 130 nmol L-thyroxine 
(T4)/kg body wt (Henning Berlin GmbH, Germany) and 
1 pmol 6-n-propyl-2-thiouracil (PTIJ)/kg body wt (Sigma, St. 
Louis, MO; USA) for at least three weeks. Euthyroid rats 
received daily S.C. injections of 0.9% NaCI. After decapitation, 
the hearts were immediately used for preparation of mitochon- 
dria. The thyroid status of all animals was verified by radioim- 
munoassay (RIA) of serum T4 and T3 [17], liver enzyme 
activities and organ weights, table 1. 
2.2, Isolation of mitochondria 
The rat hearts were immediately placed in ice-cold freshly 
prepared isolation buffer (70 mM sucrose, 220 mM mannitol, 
10 mM KMops, 0.2 mM EGTA, pH 7.2) and mitochondria 
were prepared as described [18], but without nagarse. Freshly 
prepared mitochondria in isolation buffer were diluted to 
1.2 mg protein/ml and directly used for affinity labeling. 
2.3. Affinity labeling 
BrA&‘I]T3 and BrAcT3 were synthesized as described [14] 
and purified by HPLC just before use. About 1.0 nCi of 
BrAc[‘Z51]T3 per ~1 of final assay volume (1.6 nM) was added 
to a polypropylene microtube. After the solvent (methanol) had 
been evaporated under a stream of nitrogen, the suspension of 
whole mitochondria was added to the tube, mixed thoroughly 
and incubated with occasional shaking on ice or at room 
temperature for the indicated time intervals. The reaction was 
stopped either by ethanol precipitation or by addition of sample 
buffer [19] to a final concentration of 20% and immediately 
loaded on an SDS-polyacrylamide gel. The ethanol precipita- 
tion was done by addition of two volumes of 100% ethanol, 
mixing, incubation on ice for at least IO min and centrifugation 
at 16000 x g for 10 min. The pellet, which contained the 
covalently bound label, was counted (1260 Multigamma LKB, 
Bromma, Sweden) and the supernatant, which contained the 
unbound label, was used for HPLC analysis. In the competition 
experiments, either of the compuonds BrAcT3, N- 
acetyl-3,3 ’ ,5-triiodo-L-thyronine (AcT3), 3,3’ ,5 ‘-triiodo-L- 
thyronine (rT3, Henning Berlin GmbH), iodoacetic acid, 
3-methyl-4’,6-dihydroxy-3’ ,5’-dibromo-flavone (EMD 21388, 
Drs Pruecher and Irmscher, Merck, Darmstadt, FRG), ATP or 
ADP were added to the mitochondrial suspension to a final 
concentration of 5 gM and preincubated on ice for 2 h before 
affinity labeling as described above. Carboxyatractylate 
(Boehringer Mannheim, FRG) or bongkrekic acid (Dr Boos, 
Paderborn, FRG) were added to the mitochondrial suspension 
to a final concentration of 10 /cM with or without 100 ,uM ATP, 
and incubation on ice was continued for 20 min before the af- 
finity labeling. 
2.4. HPLC analysb 
Ethanol supernatants were diluted with 0.1% trifluoroacetic 
acid to a final concentration of 20% ethanol (v/v) and adsorbed 
on a r-Bondapak Cl8 reversed-phase column (4.6 x 250 mm, 
Waters Associates, Milford, MA, USA) equipped with a 2 ml 
Cl8 guard column. Elution was done with a gradient of 
acetonitrile (with a constant concentration of 0.1% 
trifluoroacetic acid): O-3 min 35% isocratic, 3-18 min 
35-75% linear, 18-25 min 75-90% linear and 25-35 min 90% 
isocratic, with a flow rate of 1 ml/min. Radioactivity and UV 
absorption at 254 nm of the eluate were continuously 
monitored by the Berthold HPLC chromatography system LB 
510. 
2.5. SDS-polyacrylamide gel electrophoresis and auto- 
radiography 
SDS-PAGE and staining with Coomassie brilliant blue or 
silver was performed as described [19]. The dried gels were ex- 
posed to Kodak direct exposure films, DEF-2, for 24 h. By 
superimposing the film on the stained gel, the identity of the 
affinity-labeled bands was determined. 
2.6. Protein determination 
Determination of total protein was done with the Bio-Rad 
Protein Assay using bovine serum albumin as standard. Scann- 
Table 1 
Effects of T4 and PTU on serum hormone levels, heart weight, and hormone dependent enzymes in the liver 
Treatment Serum T3 
(nM) 
Serum T4 Heart weight BW gain a-GPDH T4-5 ’ -deiodinase Malic enzyme 
(nM) (9) (g/day) (mU/mg) (pmol T3. min-’ . WJ/mg) 
mg-’ . protein) 
Saline 1.29 k 0.24 94 f 48 0.99 + 0.07 2.42 2422 f 8814 28.3 f 17 12.2 + 2.8 
(n = 7) (n = 7) (n = 3) (n = 7) (n = 3) (n = 4) (n = 5) 
L-Thyroxine 2.41 + 0.16 242 + 100 1.38 + 0.16 2.03 8634 * 4962 105 f 24 14.3 + 9.6 
(n = 5) (n = 5) (n = 3) (n = 5) (n = 4) (it = 4) (n = 4) 
Propylthiouracil 0.66 + 0.21 <20 0.90 f 0.0 
(n’ T3) 
357 * 155 
(n = 3) (n = 3) (n = 3) (n = 3) (nrl3) 
6.7 + 5.0 
(n = 3) 
15 male Lewis rats were treated as described in section 2 starting 7 weeks after birth. Initial body weight (BW) was 221 g (+ 17, n = 
15) and initial T3 and T4 serum levels were 1.36 nM (k 0.20, n = 15) and 13 1 nM ( f 57, n = 15), respectively. The given values are 
from the day of decapitation. The values are calculated averages + the range of individual measurements, and n = number of rats, 
c~-GPDH = cy-glycerol phosphate dehydrogenase 
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ing of the stained gels was performed by a laser densitometer 
(LKB, Ultroscan 2202) and relative protein quantitation by an 
automatic integrator (LKB, 2220 recording integrator). 
3. RESULTS 
3.1. Affinity labeling of whole heart mitochondria 
No labeling of the ATN (7% of mitochondrial 
protein [19]) was seen when intact mitochondria 
were affinity labeled with BrAc[“‘I]T3. Prein- 
cubation of the mitochondria with excess (5 pM) 
of either of the two specific ANT inhibitors, car- 
boxyatractylate or bongkrekic acid [20], or with 
the substrates ADP or ATP, did not result in label- 
ing of the ANT. Instead two closely migrating 
bands with an approximate molecular mass of 
49200 and 48000 Da were strongly and equally af- 
finity labeled, fig. 1. The two labeled bands com- 
igrated with stained bands 4 and 5 in fig.2, while 
the ANT was band 7. The abundance of bands 4 
and 5 is about 2.8 and 3.0%, respectively of total 
mitochondrial protein, determined by averaging 
gel scanning values. Labeling intensity increases 
with time and temperature, fig.lA a-d, 1B a-c. 
Solubilization of the mitochondria with Triton 
X-100 abolished the binding of BrAc[‘251]T3 (not 
shown), indicating that the specific conformation 
of bands 4 and 5 in the intact mitochondrial mem- 
brane is essential for binding. No difference in the 
labeling pattern or intensity was seen in the hyper- 
or hypothyroid mitochondria, fig.lB, d-f. The 
stained bands 2 and 3 (fig.2) were weakly labeled 
in all the experiments. 
Fig. 1. Autoradiography of affinity-labeled rat heart 
mitochondria separated by SDS-polyacrylamide gel 
electrophoresis. Preincubation, affinity labeling with 
BrAc[“‘I]T3 (1.6 nM) of whole mitochondria (1.2 mg total 
protein/ml), SDS-PAGE and autoradiography were done as 
described in section 2. (A) Affinity labeling of normal rat 
mitochondria at 0°C for 5 s (a), 30 min (b), 2 h (c), and 5 h (d). 
Preincubation for 2 h with 5 PM of each BrAcT3 (e), AcT3 (f), 
T3 (g), rT3 (h), iodoacetic acid (i), and EMD 21388 (j) before 
affinity labeling for 5 h (as in d). (B) Affinity labeling of 
normal rat mitochondria at room temperature for 5 s (a), 
30 min (b) and 5 h (c). Affinity labeling at 0°C for 5 h with 
normal rat mitochondria (d), mitochondria from TCtreated (e), 
and PTU-treated rats (f). Lane (g) was treated as in (d) but 
PAGE sample buffer was added before incubation with 
BrAc[rZSI]T3. The strongly labeled band is actually two closely 
migrating equally labeled bands identified as bands 4 and 5 in 
fig.2 by superimposing the film on the stained gel. Film A and 
B were exposed for 24 h. kfr x IO-’ values are shown to the left. 
Saturation of labeling is not reached before 
substantial degradation of the remaining unbound 
label is seen by HPLC analysis, 9% of the added 
BrAc[?]T3 is bound to mitochondria after 
30 min incubation on ice and 85% of the remain- 
abcdefghi j 
abcdefg 
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Fig.2. SDS-PAGE, silver staining and gel scanning of total rat heart mitochondria. 2.5 yg protein per lane from normal (a), T4-treated 
(b), PTU-treated (c) and solubilized normal (d) mitochondria. 55 ng of each (M) bovine serum albumin (68 kDa), ovalbumin (45 kDa), 
carbonic anhydrase (29 kDa) and cytochrome c (12.5 kDa). A densitometric laser scan of lane (a) is shown to the right; the peak areas 
were automatically calculated by an integrator. The numbered bands are referred to in the text. Band 7 corresponds to the ANT. A& 
x lo-” values are shown to the left. 
ing unbound BrAc[‘251JT3 is still intact. After 5 h, 
30% is bound, but only 61% of the remaining un- 
bound label is intact. After 5 h incubation at room 
temperature, 75% of the B~Ac[‘~‘I]T~ is bound 
and the remaining unbound label is completely 
degraded (fig.3). 
3.2. Competition with T3 and T3 analogues 
A 3000-fold excess of competitor was used in all 
experiments, Preincubation of mitochondria for 
2 h with BrAcT3 showed 67% inhibition of 
BrAc[1251]T3 binding after 5 h incubation. The 
same incubation conditions for the reversible 
binding compounds showed 35% inhibition by T3 
or rT3, 30% by AcT3 and 52% by the flavonoid 
EMD 21388, a synthetic thyroxine antago~st and 
potent competitive inhibitor of the iodothyronine 
5 ’ -deiodinase enzyme [21]. Iodoacetic acid, which 
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Fig.3. HPLC elufion profile of purified affinity label and of 
supernatant after incubation with mitochondria. HPLC was 
performed as described in section 2. IN absorbance (a) and 
radioactivity profiles (b-e) are shown. Purified BrAc[rz51]T3 
was mixed with ‘cold’ BrAcT3 and analyzed (a,b). Ethanol 
supernatants of the mitochondria after incubation with 
B~Ac[‘~~I]T~ at 0°C for 30 min (cc), 5 h (d), and after 5 h at 
room temperature (e) are shown. The numbers near the peaks 
show the percentage of totat injected cpm. 
irreversibly alkylates sulfhydryl groups, showed 
45% inhibition of BrAc[“‘I]T3 binding (fig.lA, 
d-j). Iodoacetic acid has been shown to be an 
active-site-directed reagent for iodoth~onine 
5 ’ -deiodinase and T3-binding (or -metabolizing) 
proteins where a sulfhydryl group is in close prox- 
imity to the iodothyronine binding site [22]. 
3.3. Effect of hyper- and hypothyroidism on heart 
mitochondrial proteins 
Table 1 shows the results of the treatment with 
T4 and PTU, an antithyroidal compound which 
blocks the synthesis and conversion of thyroid hor- 
mones. Experimental hyper- and hypothyroid con- 
ditions in the rats were verified by T4 and T3 
serum levels, the activity of three hormone- 
dependent liver enzymes and the differences in 
heart weight. The overall pattern of the mitochon- 
drial proteins is the same for the differently treated 
rats and the ANT abundance and mobility is clear- 
ly unchanged (fig.2). However, five bands show 
changes in relative abundance; these bands are 
labeled 1,6,8,9 and 10. The functional identity of 
these proteins is unknown, thus they may be either 
nuclear or mitochondrial coded. 
4. DISCUSSION 
In vivo T3 administration to rats induces a 
decrease of the ATPlADP ratio in the mitochon- 
dria and an increase in the cytosol [6], and the 
thyroid state has been reported to influence the 
kinetics of the ANT in liver [7]. We found no label- 
ing of the rat heart ANT by BrAc[‘2SI]T3 using dif- 
ferent experimental conditions. This indicates that 
the ANT is not a direct target for T3 binding, but 
its activity may instead be indirectly regulated, i.e. 
through contact with other T3-binding proteins or 
by T3-induced changes in the lipid matrix of the in- 
ner mitochondrial membrane 1231. Also, we found 
that the abundance and mobility of the ANT in the 
rat heart is unaffected by the thyroid state. A pro- 
tein from rat liver mitochondria, which was 
reported to bind T3, has been purified by affinity 
chromatography and characterized; it has a 
molecular mass of 28000 Da and the amino acid 
composition is known [24]. The two most abun- 
dant proteins in this size range in rat heart 
mitochondria are the ANT and the closely 
migrating phosphate transport p otein (PTP) [ 111. 
Amino acid compositions are known for both the 
ANT and PTP protein from beef heart [ 19,251, but 
none of them are similar to the reported amino 
acid composition of the rat liver mitochondrial T3 
binding protein. 
Two closely migrating proteins with a molecular 
mass of 48000 and 49200 Da were strongly label- 
ed, and labeling was competed for by T3 and other 
analogues. These two proteins may be directly in- 
volved in T3 regulation of mitochondrial activity. 
No difference in the labeling by BrAc[12SI]T3 was 
seen in hyper- or h~othyroid rats. The 
physiological function of the two affinity-labeled 
proteins described here, as well as the five proteins 
with changed abundancy in hypo- and hyper- 
thyroid rat hearts still has to be resolved. 
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